共 50 条
- [44] Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma ONCOLOGIST, 2022, 27 (11): : E856 - E869
- [46] Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer ONCOLOGIST, 2015, 20 (08): : 896 - 897
- [48] Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial ONCOLOGIST, 2023, 28 (09): : 827 - +
- [50] Evaluation of safety of bevacizumab as second-line treatment of patients with metastatic colorectal cancer JOURNAL OF BUON, 2017, 22 (05): : 1131 - 1136